scholarly article | Q13442814 |
P50 | author | Tammy Dugas | Q73521649 |
P2093 | author name string | Valeria Y Hebert | |
Mitzi Glover | |||
Stephen Y Xue | |||
Corie N Robinson | |||
Danicia M Hayes | |||
P2860 | cites work | Nix, a receptor protein for mitophagy in mammals | Q24301612 |
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 | ||
Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells | Q43258050 | ||
A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults | Q43580186 | ||
NADH: sensor of blood flow need in brain, muscle, and other tissues. | Q43626588 | ||
The mitochondrial permeability transition initiates autophagy in rat hepatocytes. | Q43711895 | ||
Endothelin-1 production is enhanced by rotenone, a mitochondrial complex I inhibitor, in cultured rat cardiomyocytes | Q43798796 | ||
Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver | Q44005668 | ||
Antiretrovirals induce direct endothelial dysfunction in vivo. | Q44083807 | ||
Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide | Q44185615 | ||
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study | Q44486385 | ||
Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation. | Q45061915 | ||
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use | Q56830806 | ||
HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis | Q64377031 | ||
Coronary heart disease in HIV-infected individuals | Q73687564 | ||
Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy | Q81110657 | ||
Selective degradation of mitochondria by mitophagy | Q24658163 | ||
Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 | Q28131760 | ||
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension | Q28301973 | ||
The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction | Q28386344 | ||
Mitochondria, oxidants, and aging | Q29547594 | ||
Antiretrovirals induce endothelial dysfunction via an oxidant-dependent pathway and promote neointimal hyperplasia | Q30430542 | ||
Mitochondrial degradation by autophagy (mitophagy) in GFP-LC3 transgenic hepatocytes during nutrient deprivation | Q30498226 | ||
Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway | Q33522876 | ||
Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes | Q33556360 | ||
Autophagy in health and disease. 5. Mitophagy as a way of life | Q34085696 | ||
Mitochondrial pruning by Nix and BNip3: an essential function for cardiac-expressed death factors | Q34121511 | ||
Signaling pathways in mitochondrial dysfunction and aging | Q34170340 | ||
Mitochondrial disease: a pulmonary and critical-care medicine perspective | Q34335818 | ||
Autophagy: assays and artifacts | Q34341096 | ||
Pharmacokinetics of tenofovir disoproxil fumarate and ritonavir-boosted saquinavir mesylate administered alone or in combination at steady state | Q34510726 | ||
Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging | Q34556311 | ||
Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. | Q35564144 | ||
Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria | Q35601295 | ||
Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs | Q35879021 | ||
Direct, DNA pol-gamma-independent effects of nucleoside reverse transcriptase inhibitors on mitochondrial bioenergetics | Q35911365 | ||
Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis | Q36017632 | ||
Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation | Q36535244 | ||
Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation | Q36870637 | ||
Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction | Q37270571 | ||
Oxidative stress, endothelial dysfunction and atherosclerosis. | Q37597217 | ||
Autophagy and the degradation of mitochondria | Q37677293 | ||
Autophagosome formation and molecular mechanism of autophagy. | Q37780202 | ||
Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. | Q38021399 | ||
HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. | Q38296946 | ||
Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors | Q38568978 | ||
Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I. | Q39853002 | ||
Mitochondrial toxicity of antiviral drugs | Q40429889 | ||
Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential | Q40541135 | ||
Nuclear control of respiratory chain expression in mammalian cells | Q41547358 | ||
Endothelial cell monolayers as a tool for studying microvascular pathophysiology | Q41685270 | ||
Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy. | Q42285194 | ||
Allosteric nucleotide-binding site in the mitochondrial NADH:ubiquinone oxidoreductase (respiratory complex I). | Q42823476 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 2 | |
P921 | main subject | endothelium | Q111140 |
cytotoxicity | Q246181 | ||
ubidecarenone | Q321285 | ||
P304 | page(s) | 323-334 | |
P577 | publication date | 2013-05-02 | |
P1433 | published in | Toxicological Sciences | Q2446966 |
P1476 | title | Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment | |
P478 | volume | 134 |
Q44797235 | Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity. |
Q51538858 | Drug-Induced Mitochondrial Toxicity. |
Q37165704 | Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy |
Q34759994 | Increased coronary vessel wall thickness in HIV-infected young adults |
Q39565701 | Mitochondrial compromise in 3-year old patas monkeys exposed in utero to human-equivalent antiretroviral therapies |
Q46130631 | Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells |
Q47574017 | Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV Therapeutics |
Q35556516 | Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction. |